News

Drug Briefing: Daprodustat

Views: 55     Author: Unibest Industrial     Publish Time: 2024-07-29      Origin: Site

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button

Query Drug：Daprodustat

Query Time：2024-08-27 13:16:03

*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest does NOT accept legal responsibility for ANY medical actions taken based on this information. ALWAYS consult with your doctor for medical advice. In addition, this product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

About the Drug

Daprodustat is used to treat anemia caused by chronic kidney disease in adults who have been on dialysis for at least 4 months.

Daprodustat may also be used for purposes not listed in this medication guide.

Related Diseases

Disease(s) related to Daprodustat include：anemia, chronic-kidney-disease. In terms of each disease, here are other alternative drugs：

anemia

Drug Name Rating Reviews Rx/OTC Brandname Drug?
epoetin alfa 3.8 5 Rx False
multivitamin with iron 8.3 17 Rx/OTC False
Vitamin B6

Rx/OTC True
Procrit 2.5 4 Rx True
Revlimid

Rx True
lenalidomide

Rx False
Reblozyl 10 1 Rx True
Epogen 9.0 1 Rx True
Ferralet 90 0.0 1 Rx/OTC True
Integra 10 1 Rx/OTC True
Anadrol-50

Rx False
pyridoxine 3.0 1 Rx/OTC False
Integra Plus

Rx/OTC True
Iron-150

Rx/OTC True
Aminoxin

Rx/OTC True
Fusion Plus

Rx/OTC True
Ferocon

Rx/OTC True
Integra F 9.0 1 Rx/OTC True
Chromagen

Rx/OTC True
Ferrex 150 Forte

Rx/OTC True
Retacrit

Rx True
ferrous gluconate

Rx/OTC False
BiferaRx

Rx/OTC True
Dialyvite

Rx/OTC True
Ferrex 150 Forte Plus

Rx/OTC True
ferrous fumarate

Rx/OTC False
Multigen

Rx/OTC True
EnLyte

Rx/OTC True
Ferrex 28

Rx/OTC True
FoliTab 500

Rx/OTC True
luspatercept 10 1 Rx False
Multigen Plus

Rx/OTC True
Nephron-FA

Rx/OTC True
Taron Forte

Rx/OTC True
Active Fe

Rx/OTC True
Hematogen Forte 10 1 Rx/OTC True
Iferex 150 Forte

Rx/OTC True
Irospan 24/6

Rx/OTC True
Maxaron Forte 6.3 3 Rx/OTC True
Multigen Folic

Rx/OTC True
Nufera

Rx/OTC True
Tricon

Rx/OTC True
Cerovite Junior

Rx/OTC True
Flintstones Complete

Rx/OTC True
MyKidz Iron

Rx/OTC True
Reference: drugs.com



chronic-kidney-disease

Drug Name Rating Reviews Rx/OTC Brandname Drug?
Farxiga 6.5 13 Rx True
Kerendia 8.0 2 Rx True
dapagliflozin 6.5 13 Rx False
finerenone 8.0 2 Rx False
Jardiance

Rx True
empagliflozin

Rx False
Reference: drugs.com



Extra Information on Drug and Diseases

Drug daprodustat

RXCUI: 2628210

May Treat

  • Anemia

Similar Drugs

[may_treat] Anemia

Source MEDRT

[Physiological Effect] Increased Transcription to RNA

Source: MEDRT

[Mechanism of Action] Hypoxia-inducible Factor Inhibitors

Source MEDRT

[Mechanism of Action] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors

Source FDASPL

[Mechanism of Action] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors

Source DAILYMED

[Phamacological Category] Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor

Source FDASPL

[Phamacological Category] Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor

Source DAILYMED

Orange Book

[Last update] 2024-08-09

Labelers

Daprodustat's Innovator is GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND

Drug Products

The unique dosage forms from the innovator include：1. TABLET;ORAL.

Index Route Brand Name Labeler Approval Date Dosage
1 TABLET;ORAL JESDUVROQ GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND Feb 1, 2023 4MG
2 TABLET;ORAL JESDUVROQ GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND Feb 1, 2023 1MG
3 TABLET;ORAL JESDUVROQ GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND Feb 1, 2023 8MG
4 TABLET;ORAL JESDUVROQ GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND Feb 1, 2023 6MG
5 TABLET;ORAL JESDUVROQ GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND Feb 1, 2023 2MG

Drug Patents

This drug still has 6 effective patents.

Patent Number Submission Date Expiration Date Drug Substance Patent? Drug Product Patent?
11117871 Feb 21, 2023 Mar 13, 2038 Y Y
8815884 Feb 21, 2023 Jun 22, 2027
Y
8557834 Feb 21, 2023 Jun 22, 2027

8324208 Feb 21, 2023 Dec 11, 2028 Y Y
11649217 Jun 7, 2023 Mar 13, 2038
Y
11643397 Jun 7, 2023 Jun 22, 2027 Y

Daprodustat Patent Scope

Related Company's Product Pipelines

The innovator GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND's portolio contains products with the following 2 API(s)： DAPRODUSTAT, CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

The above products are related to 10 diseases： Anemia, Otitis Media, Haemophilus Infections, Staphylococcal Infections, Respiratory Tract Infections, Soft Tissue Infections, Urinary Tract Infections, Skin Diseases, Infectious, Sepsis, Pseudomonas Infections

GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND Diseases Covered

Drug analysis Daprodustat Patent Expiration